Evidence map›Paper›PMID 33115859›Full record

ArticleBMJ global health2020

Bridging research integrity and global health epidemiology (BRIDGE) statement: guidelines for good epidemiological practice.

Sandra Alba, Kristien Verdonck, Annick Lenglet, Susan F Rumisha, Martijn Wienia, Imre Teunissen, Masja Straetemans, Walter Mendoza, Daniel Jeannetot, Daniel Weibel and 2 more

Abstract read
In one paragraph

Article in BMJ global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Tackling the lack of diversity in cancer research.Disease models & mechanisms · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sandra AlbaHealth, KIT Royal Tropical Institute, Amsterdam, The Netherlands s.alba@kit.nl.ORCID 0000-0003-2435-624X
Kristien VerdonckTropical Diseases, Institute of Tropical Medicine, Antwerp, Belgium.
Annick LengletMédecins Sans Frontières, Amsterdam, The Netherlands.
Susan F RumishaNational Institute for Medical Research, Dar es Salaam, Tanzania, United Republic of.
Martijn WieniaNWO-WOTRO Science for Global Development, The Hague, The Netherlands.
Imre TeunissenHealth, KIT Royal Tropical Institute, Amsterdam, The Netherlands.
Masja StraetemansHealth, KIT Royal Tropical Institute, Amsterdam, The Netherlands.
Walter MendozaUnited Nations Population Fund, Lima, Peru.
Daniel JeannetotHealth, KIT Royal Tropical Institute, Amsterdam, The Netherlands.
Daniel WeibelEDCTP, The Hague, The Netherlands.
Harriet Mayanja-KizzaSchool of Medicine, Makerere University, Kampala, Uganda.
Sanjay JuvekarVadu Rural Health Program, KEM Hospital Research Centre, Pune, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResearch integrity and research fairness have gained considerable momentum in the past decade and have direct implications for global health epidemiology. Research integrity and research fairness principles should be equally nurtured to produce high-quality impactful research-but bridging the two can lead to practical and ethical dilemmas. In order to provide practical guidance to researchers and epidemiologist, we set out to develop good epidemiological practice guidelines specifically for global health epidemiology, targeted at stakeholders involved in the commissioning, conduct, appraisal and publication of global health research.

methodsWe developed preliminary guidelines based on targeted online searches on existing best practices for epidemiological studies and sought to align these with key elements of global health research and research fairness. We validated these guidelines through a Delphi consultation study, to reach a consensus among a wide representation of stakeholders.

resultsA total of 45 experts provided input on the first round of e-Delphi consultation and 40 in the second. Respondents covered a range of organisations (including for example academia, ministries, NGOs, research funders, technical agencies) involved in epidemiological studies from countries around the world (Europe: 19; Africa: 10; North America: 7; Asia: 5; South-America: 3 Australia: 1). A selection of eight experts were invited for a face-to-face meeting. The final guidelines consist of a set of 6 standards and 42 accompanying criteria including study preparation, protocol development, data collection, data management, data analysis, dissemination and communication.

conclusionWhile guidelines will not by themselves guard global health from questionable and unfair research practices, they are certainly part of a concerted effort to ensure not only mutual accountability between individual researchers, their institutions and their funders but most importantly their joint accountability towards the communities they study and society at large.

Indexed as

Global HealthAfricaEuropeHumansepidemiology

Identifiers

PMID33115859
PMCPMC7594207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.